The Patent Finder
JO

Jointechlabs, Inc.

First filing 2011
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Seven patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jul 2031. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jul 2031
Next term end
3
Patent families

When these terms end

Each bar runs from grant to computed term end. 2018 to 2042.
US 9,938,501 Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use Jul 28, 2031
US 11,447,748 Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use Oct 14, 2031
US 10,745,666 Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Therapeutic Use Jun 4, 2032
US 9,931,445 System and Methods for Preparation of Adipose-Derived Stem Cells Jul 9, 2032
US 10,967,110 System and Methods for Preparation of Adipose-Derived Stem Cells Jul 9, 2032
US 12,239,669 System and Methods for Preparation of Adipose-Derived Stem Cells Apr 2, 2039
US 11,766,459 System and Methods for Preparation of Adipose-Derived Stem Cells Jun 14, 2042
20232028203320382042
1 pending application: term is not computable until grant.Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 26, 2027
    The maintenance fee for System and Methods for Preparation of Adipose-Derived Stem Cells (US 11,766,459) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 9,938,501Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use
In force
 · High confidence
In forceHigh confidence
US 11,447,748Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use
In force
 · High confidence
In forceHigh confidence
US 10,745,666Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Therapeutic Use
In force
 · High confidence
In forceHigh confidence
US 9,931,445System and Methods for Preparation of Adipose-Derived Stem Cells
In force
 · High confidence
In forceHigh confidence
US 10,967,110System and Methods for Preparation of Adipose-Derived Stem Cells
In force
 · High confidence
In forceHigh confidence
US 12,239,669System and Methods for Preparation of Adipose-Derived Stem Cells
In force
 · Medium confidence
In forceMedium confidence
US 11,766,459System and Methods for Preparation of Adipose-Derived Stem Cells
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 7: 1 application pending · 1 application abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited